T1	Participants 94 161	younger patients with nonacute promyelocytic acute myeloid leukemia
T2	Participants 351 457	younger patients with nonacute promyelocytic acute myeloid leukemia and high-risk myelodysplastic syndrome
T3	Participants 537 576	1075 patients less than 60 years of age
